We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

68 hedge funds and large institutions have $446M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 7

175% more capital invested

Capital invested by funds: $162M → $446M (+$284M)

162% more funds holding

Funds holding: 26 → 68 (+42)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

4% more call options, than puts

Call options by funds: $968K | Put options by funds: $927K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
68
Holders Change
+42
Holders Change %
+161.54%
% of All Funds
1.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
49
Increased
8
Reduced
7
Closed
7
Calls
$968K
Puts
$927K
Net Calls
+$41K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$48.1M
2
Franklin Resources
Franklin Resources
California
+$28M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.2M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$19.5M
5
Wells Fargo
Wells Fargo
California
+$19.2M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$13.4M
2
Millennium Management
Millennium Management
New York
-$8.67M
3
PC
Pier Capital
Connecticut
-$4.94M
4
BBA
Baker Bros. Advisors
New York
-$3.91M
5
VM
VHCP Management
New York
-$3.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
51
US Bancorp
Minnesota
$23K +$23.4K +393 New
ST
52
Stifel Trust
Missouri
$18K +$17.8K +300 New
TRCT
53
Tower Research Capital (TRC)
New York
$14K +$14.5K +243 New
Invesco
54
Invesco
Georgia
$13K +$13.5K +227 New
LTFS
55
Ladenburg Thalmann Financial Services
Florida
$12K – – –
LFG
56
LifePlan Financial Group
Ohio
$11K – – –
CFA
57
CT Financial Advisors
Pennsylvania
$9.11K +$5.95K +100 New
BRWM
58
B. Riley Wealth Management
Tennessee
$9K +$8.92K +150 New
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$6K – – –
Ameriprise
60
Ameriprise
Minnesota
$6K +$5.53K +93 New
MSFP
61
Mark Sheptoff Financial Planning
Connecticut
$6K +$5.95K +100 New
MFS
62
MSI Financial Services
Massachusetts
$6K +$5.95K +100 New
ARMC
63
American Research & Management Company
Massachusetts
$3K +$2.97K +50 New
TDC
64
Thompson Davis & Co
Virginia
$3K +$2.97K +50 New
WA
65
WFG Advisors
Texas
$3K +$2.97K +50 New
Barclays
66
Barclays
United Kingdom
$1K -$1.72M -28,883 -100%
PFG
67
Piershale Financial Group
Illinois
$1K +$1.19K +20 New
PC
68
Pier Capital
Connecticut
– -$4.94M -119,006 Closed
BBA
69
Baker Bros. Advisors
New York
– -$3.91M -94,172 Closed
VAM
70
Visium Asset Management
New York
– -$2.5M -60,291 Closed
Neuberger Berman Group
71
Neuberger Berman Group
New York
– -$955K -23,000 Closed
AIG
72
American International Group
New York
– -$275K -6,618 Closed
HAMF
73
Hatteras Alternative Mutual Funds
North Carolina
– -$249K -6,000 Closed
Renaissance Technologies
74
Renaissance Technologies
New York
– -$212K -5,100 Closed
WA
75
Waverly Advisors
Alabama
– +$119 +2 New
1 2
3

GWPH Hedge Fund Activity: Q1 2014 in Review

68 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2014, worth a combined $446M — up 175% from $162M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new GWPH positions and 7 closed out — a net gain of 42 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $48.1M. The largest seller was OrbiMed, cutting an estimated $13.4M.

  • 68 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2014, up from 26 in Q4 2013.
  • Funds reported $446M of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2014, up 175% quarter-over-quarter.
  • 49 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2014 and 7 closed out, a net change of +42 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2014 was Capital Research Global Investors, an estimated $48.1M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2014 was OrbiMed, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2014.